| 000 | 01718 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518000846.0 | ||
| 264 | 0 | _c20191023 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01470-18 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLouie, Arnold | |
| 245 | 0 | 0 |
_aActivity of Moxifloxacin against _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c12 2018 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aColony Count, Microbial |
| 650 | 0 | 4 |
_aCulture Media _xchemistry |
| 650 | 0 | 4 | _aDiffusion Chambers, Culture |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolic Networks and Pathways |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aMoxifloxacin _xpharmacokinetics |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aStreptomycin _xpharmacology |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 700 | 1 | _aDuncanson, Brandon | |
| 700 | 1 | _aMyrick, Jenny | |
| 700 | 1 | _aMaynard, Michael | |
| 700 | 1 | _aNole, Jocelyn | |
| 700 | 1 | _aBrown, David | |
| 700 | 1 | _aSchmidt, Stephan | |
| 700 | 1 | _aNeely, Michael | |
| 700 | 1 | _aScanga, C A | |
| 700 | 1 | _aPeloquin, Charles | |
| 700 | 1 | _aDrusano, G L | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 62 _gno. 12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01470-18 _zAvailable from publisher's website |
| 999 |
_c28869223 _d28869223 |
||